greeksoup/ stock research

Metlife (MET) FY2021 results: revenue $68.7 billion, up 1.3% on the year

Metlife Inc. (MET) reported revenue of $68.7 billion for fiscal 2021, the year ended 31 December 2021, up 1.3% on the year before. Net income was $6.9 billion, up 26.8%, and diluted earnings per share $7.65. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2022.

Revenue
$68.7 billion
+1.3% on the year
FY2014FY2021
Operating margin
12.4%
10.2% a year earlier
FY2014FY2021
Net income
$6.9 billion
+26.8% on the year
FY2014FY2021
Diluted EPS
$7.65
+34.7% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue68,69667,84269,620+1.3%
Operating income8,5186,9276,795+23.0%
Operating margin12.4%10.2%9.8%
Interest expense647632656+2.4%
Pre-tax income8,5186,9276,795+23.0%
Income tax1,6421,509886+8.8%
Effective tax rate19.3%21.8%13.0%
Net income6,8555,4075,899+26.8%
Net margin10.0%8.0%8.5%
Diluted EPS$7.65$5.68$6.06+34.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow12,34711,63913,786+6.1%
Cash from investing-11,187-18,569-17,586
Cash from financing-1,12610,7294,568
Depreciation and amortisation223235249-5.1%
Share-based compensation173127150+36.2%
Buybacks4,3031,1512,285+273.8%
Dividends paid1,6471,6571,643-0.6%
Dividend per share$1.90$1.82$1.74+4.4%
Diluted shares, weighted869m913m944m-4.8%
Shares outstanding at period end826m893m915m-7.5%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity67,48274,55866,144-9.5%
Non-controlling interest267259238+3.1%
Short-term borrowings341393235-13.2%
Debt13,93314,60313,466-4.6%
Other liabilities677,685705,333660,380-3.9%
Total liabilities and equity759,708795,146740,463-4.5%
Goodwill9,53510,1129,308-5.7%
Intangible assets9721,099335-11.6%
Investments7,1763,9043,850+83.8%
Loans79,22683,75480,282-5.4%
Trading assets12,14213,31913,102-8.8%
Cash and equivalents20,04719,79516,598+1.3%
Other assets630,610663,163616,988-4.9%
Total assets759,708795,146740,463-4.5%

10-K for the year ended 31 December 2021, filed 18 February 2022: the filing.